Crohn's Disease

Impact of Early Azathioprine Use on Crohn's Disease Progression Evaluated

October 02, 2017

Prior bowel resection, smoking, and low hemoglobin tied to Crohn's-related surgery

Biosimilar Cyltezo Gets FDA Approval for Multiple Indications

By August 28, 2017

This marks the second approval of a biosimilar for adalimumab.

Ustekinumab May Benefit Crohn's Patients Unresponsive to TNFIs

November 18, 2016

Medication potentially helpful in those for whom other treatments haven't worked